Showing 1 - 3 results of 3 for search 'Thérèse Keravis', query time: 0.02s Refine Results
  1. 1
    Disease progression in MRL/lpr lupus-prone mice is reduced by NCS 613, a specific cyclic nucleotide phosphodiesterase type 4 (PDE4) inhibitor.

    Disease progression in MRL/lpr lupus-prone mice is reduced by NCS 613, a specific cyclic nucleotide phosphodiesterase type 4 (PDE4) inhibitor. by Thérèse Keravis, Fanny Monneaux, Issaka Yougbaré, Lucien Gazi, Jean-Jacques Bourguignon, Sylviane Muller, Claire Lugnier

    Published 2012-01-01
    Get full text
    Article
  2. 2
    Concerted regulation of cGMP and cAMP phosphodiesterases in early cardiac hypertrophy induced by angiotensin II.

    Concerted regulation of cGMP and cAMP phosphodiesterases in early cardiac hypertrophy induced by angiotensin II. by Walid Mokni, Thérèse Keravis, Nelly Etienne-Selloum, Alison Walter, Modou O Kane, Valérie B Schini-Kerth, Claire Lugnier

    Published 2010-01-01
    Get full text
    Article
  3. 3
    NCS 613, a Potent PDE4 Inhibitor, Displays Anti-Inflammatory and Anti-Proliferative Properties on A549 Lung Epithelial Cells and Human Lung Adenocarcinoma Explants

    NCS 613, a Potent PDE4 Inhibitor, Displays Anti-Inflammatory and Anti-Proliferative Properties on A549 Lung Epithelial Cells and Human Lung Adenocarcinoma Explants by Issaka Yougbare, Issaka Yougbare, Lazare Belemnaba, Caroline Morin, Abdurazzag Abusnina, Yannick F. Senouvo, Thérèse Keravis, Claire Lugnier, Claire Lugnier, Eric Rousseau, Eric Rousseau

    Published 2020-08-01
    Get full text
    Article

Search Tools: